Related Experiment Video

Updated: Aug 17, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory

Marie-Priscille Brun1, Emmanuelle Braud, Delphine Angotti

  • 1Laboratoire de Pharmacochimie Moléculaire et Cellulaire INSERM U648-CNRS FRE 2718, UFR Biomédicale, 45 rue des Saints Pères, 75270 Paris Cedex 06, France.

Bioorganic & Medicinal Chemistry
|June 1, 2005
PubMed

Insights

New vitamin K3-derived compounds effectively inhibit CDC25B phosphatase activity and cancer cell proliferation. These novel naphthoquinone derivatives show promise as anticancer agents by inducing apoptosis and cell cycle arrest.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • CDC25 dual-specificity phosphatases regulate eukaryotic cell cycle progression.
  • CDC25A and B isoforms are over-expressed in various tumors and cancer cell lines.
  • CDC25s are recognized as potential targets for novel anticancer drug development.

Purpose of the Study:

  • To synthesize and evaluate novel compounds derived from vitamin K3 as inhibitors of CDC25B.
  • To assess the antiproliferative and apoptosis-inducing activities of these naphthoquinone derivatives.

Main Methods:

  • Synthesis of naphthoquinone derivatives from vitamin K3.
  • In vitro inhibition assays to determine IC50 values for CDC25B activity.
  • Antiproliferative assays using HeLa cells and clonogenic assays.
  • Analysis of CDK phosphorylation and PARP cleavage as markers of apoptosis.

Main Results:

  • Novel vitamin K3-derived compounds demonstrated significant inhibition of CDC25B activity (low micromolar IC50 values).
  • These naphthoquinone derivatives exhibited antiproliferative effects on HeLa cells and inhibited colony formation.
  • Compounds induced increased inhibitory tyrosine 15 phosphorylation of CDK and PARP cleavage, indicating apoptosis.

Conclusions:

  • Vitamin K3-derived naphthoquinones are potent inhibitors of CDC25B.
  • These compounds possess significant antiproliferative and apoptosis-inducing properties, supporting their potential as anticancer agents.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...